Khaled Yamout is the founder and CEO of Yamout Chem Consulting, LLC and he is a thought leader in analytical sciences, quality and manufacturing. He is a member of AMM and serves on multiple committees including the Science and Technology Leadership Committee. Also, he is a volunteer member with USP, where he serves as the chair of the USP Expert Panel on mRNA Vaccines. Previously he held various leadership positions with the most recent position as a Senior Director, Analytical Services and Quality Control at TriLink Biotechnologies where he oversaw the Analytical Sciences Center of Excellence and all analytical aspects of method development and validation to product release and stability to support regulatory filings for both small and large molecules. Prior to TriLink, Yamout held various positions in quality control, R&D, and manufacturing, wherein he supported several drug substances and drug products (both small molecules and biologics) from clinical phase to commercial.
Sponsored by Primrose Bio